Resumo

HEYERDAHL-VIAU, Ivo. Challenges in the employment of the orphan medications. Rev Hum Med [online]. 2023, vol.23, n.3  Epub 18-Nov-2023. ISSN 1727-8120.

The strange illnesses are those that have low prevalence and that, therefore, the development of medications to treat them is not profitable for the pharmaceutical companies due to the drop demands. Although it is already counted with different political public around the world to motivate to the pharmaceutical industries to investigate these medications, well-known as orphan medications, their development bears many difficulties in the clinical evaluations and the final price for the public it is very high. Although in recent years he/she has thought about the use of impression technology in 3D to produce these medications or even to appeal to other medications previously approved to treat strange illnesses, a record of wrong use of the legislations exists on the part of the companies with the purpose of generating commercial benefits, for what these politicians should be reinforced so that they complete its purpose; to help a very vulnerable population. The objective of the present text is to expose the results of a documental revision on the scientific and sociopolitical panorama in which is the problem of the strange illnesses and the orphan medications, as well as the possible solutions that they are spreading to approach it. It derives of a study that is developed in the current moment in the Metropolitan Autonomous University, of Mexico City.

Palavras-chave : rare diseases; orphan drug production; quality-adjusted life years; three- dimensional printing.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )